Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Faries

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Journal of the National Cancer Institute|March 21, 2022
Quantitative Nodal Burden and Mortality Across Solid CancersAnthony T Nguyen, Michael Luu, Vina P Nguyen, et al.
Annals of Surgical Oncology|November 14, 2018
Microsatellitosis in Patients with MelanomaGiorgos C Karakousis, Phyllis A Gimotty, Stanley P Leong, et al.
Journal of the American Academy of Dermatology|May 19, 2022
Patterns of recurrence and prognosis in pathologic stage I and II Merkel cell carcinoma: A multicenter, retrospective cohort analysisAndrew D Tieniber, Adrienne B Shannon, Michael J Carr, et al.
Annals of Surgical Oncology|June 1, 2012
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)J Harrison Howard, John F Thompson, Nicola Mozzillo, et al.
Annals of Surgical Oncology|July 22, 2022
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell CarcinomaAdrienne B Shannon, Richard J Straker, Michael J Carr, et al.
Melanoma Research|July 1, 2021
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanomaAlexandra M Adams, Robert C Chick, Timothy J Vreeland, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growthXimena Diaz Olea, Kristin Beede, Gabriel Pereira, et al.
Cancer Medicine|May 13, 2021
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysisRobert C Chick, Mark B Faries, Diane F Hale, et al.
Annals of Surgical Oncology|April 23, 2021
Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell CarcinomaRichard J Straker, Michael J Carr, Andrew J Sinnamon, et al.
Journal of Translational Medicine|May 4, 2012
Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011"Paolo A Ascierto, Antonio M Grimaldi, Brendan Curti, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Journal of the National Cancer Institute|March 21, 2022
Quantitative Nodal Burden and Mortality Across Solid CancersAnthony T Nguyen, Michael Luu, Vina P Nguyen, et al.
Annals of Surgical Oncology|November 14, 2018
Microsatellitosis in Patients with MelanomaGiorgos C Karakousis, Phyllis A Gimotty, Stanley P Leong, et al.
Journal of the American Academy of Dermatology|May 19, 2022
Patterns of recurrence and prognosis in pathologic stage I and II Merkel cell carcinoma: A multicenter, retrospective cohort analysisAndrew D Tieniber, Adrienne B Shannon, Michael J Carr, et al.
Annals of Surgical Oncology|June 1, 2012
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)J Harrison Howard, John F Thompson, Nicola Mozzillo, et al.
Annals of Surgical Oncology|July 22, 2022
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell CarcinomaAdrienne B Shannon, Richard J Straker, Michael J Carr, et al.
Melanoma Research|July 1, 2021
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanomaAlexandra M Adams, Robert C Chick, Timothy J Vreeland, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growthXimena Diaz Olea, Kristin Beede, Gabriel Pereira, et al.
Cancer Medicine|May 13, 2021
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysisRobert C Chick, Mark B Faries, Diane F Hale, et al.
Annals of Surgical Oncology|April 23, 2021
Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell CarcinomaRichard J Straker, Michael J Carr, Andrew J Sinnamon, et al.
Journal of Translational Medicine|May 4, 2012
Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011"Paolo A Ascierto, Antonio M Grimaldi, Brendan Curti, et al.
Pageof 15